Search Thermo Fisher Scientific
图: 1 / 3
Antibody detects endogenous levels of total TAZ.
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy, hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction. Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Barth syndrome); cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; FLJ27390; HGNC:11577; OTTHUMP00000061673; Protein G4.5; Tafazzin; tafazzin (cardiomyopathy, dilated 3A (X-linked); tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome); Taz; XX-FW83563B9.3
基因别名: 5031411C02Rik; 9130012G04Rik; AW107266; AW552613; BTHS; CMD3A; EFE; EFE2; G4.5; LVNCX; TAFAZZIN; TAZ; Taz1
UniProt ID: (Human) Q16635, (Mouse) Q91WF0
Entrez Gene ID: (Human) 6901, (Rat) 363521, (Mouse) 66826